PAMELA DUDKIEWICZ: Open Payments
NPI 1982765855 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$21,874 in 43 payments from 14 companies in 2025. Trend: 2023 $15,837 · 2024 $2,966 · 2025 $21,874
Speaker / faculty: $11,137Travel & lodging: $4,474Consulting: $4,065Food & beverage: $2,099Education: $98
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 17 | $12,013 |
| PFIZER INC. | 10 | $8,380 |
| Amgen Inc. | 1 | $250 |
| Adaptive Biotechnologies Corporation | 3 | $188 |
| Celgene Corporation | 1 | $151 |
| Deciphera Pharmaceuticals Inc. | 1 | $143 |
| BeOne Medicines USA, Inc. | 1 | $131 |
| Caris MPI, Inc. | 2 | $128 |
| BeiGene USA, Inc. | 1 | $125 |
| Janssen Biotech, Inc. | 1 | $120 |
Products named: CALQUENCE, ADCETRIS, BRUKINSA, NPLATE, clonoSEQ, REBLOZYL, QINLOCK, MI CANCER SEEK.
Industry payments across FL — which companies pay providers there.
